(Q35214119)

7 August 2017

title

Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly (English)

1 reference

7 August 2017

1 reference

Melissa M Thrall

1

1 reference

7 August 2017

Barbara A Goff

2

1 reference

7 August 2017

Rebecca Gaston Symons

3

1 reference

7 August 2017

David R Flum

4

1 reference

7 August 2017

Heidi J Gray

5

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2011

1 reference

Obstetrics and Gynecology

7 August 2017

published in

1 reference

7 August 2017

volume

118

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

537-547

1 reference

Trends in treatment of advanced epithelial ovarian cancer in the Medicare population.

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Impact of advancing age on abdominal surgical outcomes.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Enhancement of identifying cancer specialists through the linkage of Medicare claims to additional sources of physician specialty

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Organisation and quality of primary surgical intervention for ovarian cancer in Denmark.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Utility of the SEER-Medicare data to identify chemotherapy use.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Use of SEER-Medicare data for measuring cancer surgery

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Assessing comorbidity using claims data: an overview

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

The Effect of Clustering of Outcomes on the Association of Procedure Volume and Surgical Outcomes

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

The influence of hospital volume on survival after resection for lung cancer

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3173498

Outcomes in surgery for ovarian cancer

26 September 2018

1 reference

12 December 2020

Surgical care of elderly women with ovarian cancer: a population-based perspective

1 reference

12 December 2020

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

1 reference

12 December 2020

Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma

1 reference

12 December 2020

Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection

1 reference

12 December 2020

Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients

1 reference

12 December 2020

Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis

1 reference

12 December 2020

A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model

1 reference

12 December 2020

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

1 reference

12 December 2020

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

1 reference

12 December 2020

Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment

1 reference

12 December 2020

10.1097/AOG.0B013E31822A6D56

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference